152 related articles for article (PubMed ID: 21628103)
1. Chronic hepatitis B, non-Hodgkin's lymphoma, and effect of prophylactic antiviral therapy.
Kim YM; Jeong SH; Kim JW; Lee SH; Hwang JH; Park YS; Kim N; Lee JS; Kim HY; Lee DH
J Clin Virol; 2011 Aug; 51(4):241-5. PubMed ID: 21628103
[TBL] [Abstract][Full Text] [Related]
2. The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis.
Lim ST; Fei G; Quek R; Lim LC; Lee LH; Yap SP; Loong S; Tao M
Eur J Haematol; 2007 Aug; 79(2):132-7. PubMed ID: 17635237
[TBL] [Abstract][Full Text] [Related]
3. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
Huang H; Cai Q; Lin T; Lin X; Liu Y; Gao Y; Peng R
Expert Opin Pharmacother; 2009 Oct; 10(15):2399-406. PubMed ID: 19761353
[TBL] [Abstract][Full Text] [Related]
4. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers.
Wang F; Xu RH; Han B; Shi YX; Luo HY; Jiang WQ; Lin TY; Huang HQ; Xia ZJ; Guan ZZ
Cancer; 2007 Apr; 109(7):1360-4. PubMed ID: 17326056
[TBL] [Abstract][Full Text] [Related]
5. Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection.
Ulcickas Yood M; Quesenberry CP; Guo D; Caldwell C; Wells K; Shan J; Sanders L; Skovron ML; Iloeje U; Manos MM
Hepatology; 2007 Jul; 46(1):107-12. PubMed ID: 17526021
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations.
Picardi M; Pane F; Quintarelli C; De Renzo A; Del Giudice A; De Divitiis B; Persico M; Ciancia R; Salvatore F; Rotoli B
Haematologica; 2003 Nov; 88(11):1296-303. PubMed ID: 14607759
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea.
Park SC; Jeong SH; Kim J; Han CJ; Kim YC; Choi KS; Cho JH; Lee M; Jung HH; Ki SS; Chang YH; Lee SS; Park YH; Lee KH
J Med Virol; 2008 Jun; 80(6):960-6. PubMed ID: 18428141
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment with lamivudine for reactivated hepatitis B infection following chemotherapy for non-Hodgkin's lymphoma.
Stroffolini T; Andriani A; Bibas M; Barlattani A
Ann Hematol; 2002 Jan; 81(1):48-9. PubMed ID: 11807636
[TBL] [Abstract][Full Text] [Related]
9. A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial.
Hsu C; Hsiung CA; Su IJ; Hwang WS; Wang MC; Lin SF; Lin TH; Hsiao HH; Young JH; Chang MC; Liao YM; Li CC; Wu HB; Tien HF; Chao TY; Liu TW; Cheng AL; Chen PJ
Hepatology; 2008 Mar; 47(3):844-53. PubMed ID: 18302293
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy.
Koo YX; Tan DS; Tan IB; Tao M; Chow WC; Lim ST
Cancer; 2010 Jan; 116(1):115-21. PubMed ID: 19899164
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
[TBL] [Abstract][Full Text] [Related]
12. Treating chronic hepatitis B infection in patients who are pregnant or are undergoing immunosuppressive chemotherapy.
Terrault NA; Jacobson IM
Semin Liver Dis; 2007 Aug; 27 Suppl 1():18-24. PubMed ID: 17701846
[TBL] [Abstract][Full Text] [Related]
13. A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
Endo T; Sakai T; Fujimoto K; Yamamoto S; Takashima H; Haseyama Y; Nishio M; Koizumi K; Koike T; Sawada K
Bone Marrow Transplant; 2001 Feb; 27(4):433-6. PubMed ID: 11313673
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
[TBL] [Abstract][Full Text] [Related]
15. Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients.
Yeo W; Ho WM; Hui P; Chan PK; Lam KC; Lee JJ; Johnson PJ
Breast Cancer Res Treat; 2004 Dec; 88(3):209-15. PubMed ID: 15609123
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma.
Chen MH; Hsiao LT; Chiou TJ; Liu JH; Gau JP; Teng HW; Wang WS; Chao TC; Yen CC; Chen PM
Ann Hematol; 2008 Jun; 87(6):475-80. PubMed ID: 18327583
[TBL] [Abstract][Full Text] [Related]
17. Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma.
Li YH; He YF; Jiang WQ; Wang FH; Lin XB; Zhang L; Xia ZJ; Sun XF; Huang HQ; Lin TY; He YJ; Guan ZZ
Cancer; 2006 Mar; 106(6):1320-5. PubMed ID: 16470607
[TBL] [Abstract][Full Text] [Related]
18. [Lamivudine for the prevention of chronic hepatitis B exacerbations during chemotherapy for non-Hodgkin's lymphoma].
van der Eijk AA; Doorduijn JK; Janssen HL; Schalm SW; Niesters HG; de Man RA
Ned Tijdschr Geneeskd; 2002 Jun; 146(24):1140-4. PubMed ID: 12092307
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of hepatitis B virus infection to non-Hodgkin's lymphoma].
Qin XT; Lu Y; Chen XQ; Xu HP; Fan HJ
Ai Zheng; 2007 Mar; 26(3):294-7. PubMed ID: 17355794
[TBL] [Abstract][Full Text] [Related]
20. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S
Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]